Abstract
Activation of brown adipose tissue (BAT) and beige fat by cold increases energy expenditure. Although their activation is known to be differentially regulated in part by hypothalamus, the underlying neural pathways and populations remain poorly characterized. Here, we show that activation of rat-insulin-promoter-Cre (RIP-Cre) neurons in ventromedial hypothalamus (VMH) preferentially promotes recruitment of beige fat via a selective control of sympathetic nervous system (SNS) outflow to subcutaneous white adipose tissue (sWAT), but has no effect on BAT Genetic ablation of APPL2 in RIP-Cre neurons diminishes beiging in sWAT without affecting BAT, leading to cold intolerance and obesity in mice. Such defects are reversed by activation of RIP-Cre neurons, inactivation of VMH AMPK, or treatment with a β3-adrenergic receptor agonist. Hypothalamic APPL2 enhances neuronal activation in VMH RIP-Cre neurons and raphe pallidus, thereby eliciting SNS outflow to sWAT and subsequent beiging. These data suggest that beige fat can be selectively activated by VMH RIP-Cre neurons, in which the APPL2-AMPK signaling axis is crucial for this defending mechanism to cold and obesity.
Keywords
AMPK
beiging
hypothalamus
obesity
sympathetic nervous system
MeSH 主题词
AMP-Activated Protein Kinases/metabolism
Adaptor Proteins, Signal Transducing/genetics,metabolism
Adipose Tissue, Beige/metabolism
Adipose Tissue, Brown/metabolism
Adipose Tissue, White/metabolism
Animals
Energy Metabolism
Gene Deletion
Gene Knock-In Techniques
Genotype
Hypothalamus/metabolism
Mice
Mice, Knockout
Neurons/metabolism
Phenotype
Receptor-Interacting Protein Serine-Threonine Kinases/genetics,metabolism
Signal Transduction
Sympathetic Nervous System/metabolism
Thermogenesis
化学物质
Adaptor Proteins, Signal Transducing
DCC-interacting protein 13-beta, mouse
Receptor-Interacting Protein Serine-Threonine Kinases
AMP-Activated Protein Kinases
作者与单位
共 11 位作者,点击展开单位 / ORCID
Wang Baile
State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China. | Department of Medicine, The University of Hong Kong, Hong Kong, China.
Li Ang
Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Joint International Research Laboratory of CNS Regeneration Ministry of Education, Guangdong Medical Key Laboratory of Brain Function and Diseases, Jinan University, Guangzhou, China.
Li Xiaomu
Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
Ho Philip Wl
Department of Medicine, The University of Hong Kong, Hong Kong, China.
Wu Donghai
Key Laboratory of Regenerative Biology and Guangdong Provincial, Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Wang Xiaoqi
Department of Surgery, The University of Hong Kong, Hong Kong, China.
Liu Zhuohao
State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China. | Department of Medicine, The University of Hong Kong, Hong Kong, China.
Wu Kelvin Kl
Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
Yau Sonata Sy
Department of Rehabilitation Science, The Hong Kong Polytechnic University, Hong Kong, China.
Xu Aimin
ORCID
State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China amxu@hku.hk kenneth.ky.cheng@polyu.edu.hk. | Department of Medicine, The University of Hong Kong, Hong Kong, China. | Department of Pharmacology & Pharmacy, The University of Hong Kong, Hong Kong, China.
Cheng Kenneth Ky
ORCID
Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China amxu@hku.hk kenneth.ky.cheng@polyu.edu.hk.